- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Meet With Venture Capitalists, Raise Money for the LLS
If you think you're sitting on the idea of a lifetime but you lack the huge seed money to make it happen, believe it or not there are some Silicon Valley venture capitalists with deep pockets who are waiting to hear your idea. All you have to do is bid on their time, and win, with the money going to benefit the Leukemia & Lymphoma Society (LLS).
Motion To Dismiss Cancer is the name of a team created to raise money for the LLS, and one of the ways they do this is through their "Venture Capital Master's Lunch Series" auctions.
The highest bidders win face time with Silicon Valley venture caps, with whom they can get advice or pitch ideas. The list of influential men and women up for bid between 7 May and 17 May features some heavy hitters in the industry, including executives from Greylock Partners, Y Combinator, Draper Fisher Jurvetson, New Enterprise Associates, North Bridge Venture Partners, Bessemer Venture Partners, 23andMe, and RockHealth.
Since there are several lunch hour auctions per company, the bids are much lower than many might imagine, and either way the bids benefit the LLS.
Click this link to see the current auctions.
Click this one to learn more about Motion To Dismiss Cancer.